Samsung Biologics Co.,Ltd.
207940
Rankning i aktier
#498
Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon,... Samsung Biologics Co.,Ltd., established in 2011 and headquartered in Incheon, South Korea, provides contract services for biopharmaceutical products. The company's operations are divided into two main segments: Contract Manufacturing Organization (CMO) and Contract Development Organization (CDO). Its CDO services cover areas such as cell line development, optimization of upstream and downstream processes, and the formulation of analytical methods and final products. For CMO, the company offers aseptic filling, lyophilization, finishing, storage, shipping, and various associated support services. Additionally, it delivers comprehensive quality assurance, quality control, biosafety, and analytical testing. Samsung Biologics is also involved in creating and launching biosimilar drugs, alongside manufacturing mammalian cell-based antibody medications.
Aktiekurs
$1,028.49
Marknadsvärde
$47.88B
Förändring (1 dag)
-3.67%
Förändring (1 år)
-18.37%
Land
KR
Handel Samsung Biologics Co.,Ltd. (207940)
Kategori
Healthcare
P/B-tal för Samsung Biologics Co.,Ltd. (207940)
P/B-tal per October 2026 TTM: 7.59
Enligt Samsung Biologics Co.,Ltd. senaste finansiella rapporter och aktiekurs är det aktuella P/B-talet (TTM) 7.59. I slutet av 2024 hade företaget ett P/B-tal på 6.19.
Historik för P/B-tal för Samsung Biologics Co.,Ltd. från 2014 till 2026
P/B-tal vid årets slut
| År | P/B-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 7.59 | -27.89% |
| 2025 | 10.52 | 69.82% |
| 2024 | 6.19 | 8.43% |
| 2023 | 5.71 | -11.02% |
| 2022 | 6.42 | -46.93% |
| 2021 | 12.10 | 0.73% |
| 2020 | 12.01 | 80.63% |
| 2019 | 6.65 | 10.48% |
| 2018 | 6.02 | -8.12% |
| 2017 | 6.55 | 197.83% |
| 2016 | 2.20 | -43.49% |
| 2015 | 3.89 | -78.44% |
| 2014 | 18.05 | 0.00% |
P/B-tal för liknande företag eller konkurrenter
| Företag | P/B-tal | Skillnad i P/B-tal | Land |
|---|---|---|---|
| 6.6964 | -11.72% |
US
|
|
| 13.6307 | 79.69% |
US
|
|
| 4.4521 | -41.31% |
AU
|
|
| 4.2241 | -44.31% |
BE
|
|
| 6.3632 | -16.11% |
NL
|
